89bio (ETNB) | Stock Overview & Key Data

89bio Inc. | Small-cap | Healthcare

$9.43

2.61%

| 89bio Stock Comparison:

89bio vs Vertex 89bio vs Regeneron 89bio vs Cg Oncology 89bio vs Adaptive 89bio vs Vericel 89bio vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

89bio Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	89bio	Healthcare Sector	S&P 500
1 Week	2.17%	N/A	N/A
1 Month	-5.51%	N/A	N/A
3 Months	-2.28%	N/A	N/A
6 Months	-6.91%	N/A	N/A
1 Year	6.55%	N/A	N/A
3 Years	90.51%	N/A	N/A
5 Years	-75.35%	N/A	N/A

Stock Range

Today's Range

Low: $9.18 High: $9.70

on August 22, 2025

52 Week Range

Low: $4.16 High: $11.84

on April 9, 2025

on February 5, 2025

All-Time High: $47.25 on March 2, 2020

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $1.3B

EPS i -3.69

P/E Ratio (TTM) i -2.56

Forward P/E i -3.14

P/B Ratio i 2.56

PEG Ratio i -0.05

Div. Yield i N/A

ROE i -86.86%

Beta i 1.357

Debt to Equity i 7.21

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 0.00%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -49.10%

Return on Equity (TTM) i -86.86%

EBITDA i $-465.6M

Net Income (TTM) i $-450.2M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i N/A

Quarterly Revenue Growth (YoY) i N/A

Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
89bio ETNB	1.33B Small-cap	2.17%	-5.51%	-2.28%	-6.91%	18.17%	6.55%	90.51%	-75.35%
Vertex VRTX	100.19B Large-cap	0.62%	-15.94%	-8.94%	-17.95%	-2.60%	-17.90%	40.27%	46.36%
Regeneron REGN	62.88B Large-cap	1.56%	5.09%	-1.23%	-17.35%	-17.58%	-50.84%	-1.12%	-2.18%
Cg Oncology CGON	2.05B Mid-cap	4.75%	3.50%	4.50%	0.52%	-7.08%	-27.31%	-23.18%	-23.18%
Adaptive ADPT	1.92B Small-cap	-0.31%	23.46%	47.06%	54.39%	110.02%	167.70%	24.14%	-68.12%
Vericel VCEL	1.80B Small-cap	2.07%	-2.50%	-10.51%	-29.24%	-32.81%	-24.87%	36.79%	126.21%

Ownership & Short Interest

Insider Ownership i 0.54%

Institutional Ownership i 111.95%

Shares Short i 16M

Short Ratio i 11.30

Short % of Shares Outstanding i 14.73%

Average 10-Day Volume i 2M

Average 90-Day Volume i 1M

89bio Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in 89bio would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of 89bio, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: 2.17%
1 Month: -5.51%
3 Months: -2.28%
1 Year: 6.55%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is ETNB's 52-week high and low?

In the last 52 weeks, 89bio reached a high of $11.84 (on February 5, 2025) and a low of $4.16 (on April 9, 2025).

What is the market cap and P/E ratio for ETNB?

Curious about 89bio's size and valuation? Its market capitalization stands at 1.33B. When it comes to valuation, the P/E ratio (trailing twelve months) is -2.56, and the forward P/E (looking ahead) is -3.14.

Does ETNB pay dividends? If so, what's the yield?

As for dividends, 89bio isn't currently offering a significant yield, or that specific data isn't available right now.

Who are 89bio's main competitors or similar companies to consider before investing?

When looking at 89bio, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	100.19B	Healthcare	Biotechnology	-17.90%	40.27%
Regeneron REGN	62.88B	Healthcare	Biotechnology	-50.84%	-1.12%
Cg Oncology CGON	2.05B	Healthcare	Biotechnology	-27.31%	-23.18%
Adaptive ADPT	1.92B	Healthcare	Biotechnology	167.70%	24.14%
Vericel VCEL	1.80B	Healthcare	Biotechnology	-24.87%	36.79%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for 89bio Inc.? (e.g., ROE, Debt/Equity)

To get a sense of 89bio's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -86.86%, the Debt to Equity ratio from the most recent quarter is 7.21, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for ETNB?

Looking at 89bio's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of ETNB stock is held by insiders and institutions?

Wondering who owns 89bio stock? Company insiders (like executives and directors) hold about 0.54% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 111.95%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.